The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mechanisms of resistance (MoR) to DNA damaging therapy (tx) in BRCA1/2-deficient (d) metastatic breast cancer (MBC).
 
Adrienne Gropper Waks
No Relationships to Disclose
 
Ofir Cohen
No Relationships to Disclose
 
Karla Helvie
No Relationships to Disclose
 
Maxwell R. Lloyd
No Relationships to Disclose
 
Lori Marini
No Relationships to Disclose
 
Coyin Oh
No Relationships to Disclose
 
Nelly Oliver
No Relationships to Disclose
 
Neal Ian Lindeman
No Relationships to Disclose
 
Ursula A. Matulonis
Consulting or Advisory Role - AstraZeneca; Genentech; Immunogen; Merck KGaA; Tesaro
 
Ian E. Krop
Employment - Vertex (I)
Leadership - Vertex (I)
Stock and Other Ownership Interests - Vertex (I)
Consulting or Advisory Role - Amgen
Research Funding - Genentech
Travel, Accommodations, Expenses - Bayer
 
Levi A. Garraway
Stock and Other Ownership Interests - Foundation Medicine
Consulting or Advisory Role - Boehringer Ingelheim; Foundation Medicine; Novartis; Warp Drive Bio
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute
Travel, Accommodations, Expenses - Bayer; Genentech
 
Eric P. Winer
Honoraria - Verastem
Consulting or Advisory Role - Genentech/Roche; Novartis; Verastem
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Nancy U. Lin
Consulting or Advisory Role - Novartis
Research Funding - Array BioPharma; Genentech; Geron; GlaxoSmithKline; Kadmon; Novartis
 
Nikhil Wagle
Stock and Other Ownership Interests - Foundation Medicine